| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be41078385205036f284d26d8a1a2c87 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 |
| filingDate |
2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df200838116b56d31ac5c20a97c9103b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d43d49ccfe3665b919d1bbf7270a09b |
| publicationDate |
2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011244877-B2 |
| titleOfInvention |
Hemostatic implant |
| abstract |
Hemostatic Implant Abstract s The present disclosure relates to collagen-containing implants including a porous substrate having a first hydrogel precursor and a second hydrogel precursor applied thereto in a manner such that the first hydrogel precursor and second hydrogel precursor do not react with each other until the implant is placed at the site of implantation and exposed to the physiological fluids of a patient. FIG. 1Bl |
| priorityDate |
2008-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |